Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith H Aberle

Showing results (41-50 of 79) with videos related to

Pageof 8
Sort By:
Journal of Virology|May 3, 2014
Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope predictionJulia Schwaiger, Judith H Aberle, Karin Stiasny, et al.
Open Forum Infectious Diseases|July 25, 2022
The First Case of Usutu Virus Neuroinvasive Disease in Austria, 2021Marianne Graninger, Stefan Hubmer, Franz Riederer, et al.
The Journal of Infectious Diseases|November 12, 2010
Dynamic coinfection with multiple viral subtypes in acute hepatitis CJennifer A Smith, Judith H Aberle, Vicki M Fleming, et al.
The Journal of Infectious Diseases|April 3, 2007
CD4+ T cell responses in patients with chronic hepatitis C undergoing peginterferon/ribavirin therapy correlate with faster, but not sustained, viral clearanceJudith H Aberle, Gabriela Perstinger, Lukas Weseslindtner, et al.
European Journal of Preventive Cardiology|October 6, 2022
Immune response after mRNA COVID-19 vaccination in heart transplant recipients: long-term follow-up and evaluation of a third vaccinationSelma Tobudic, Keziban Uyanik-Ünal, Maximilian Koblischke, et al.
NPJ Vaccines|August 4, 2023
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variantsDavid N Springer, Michael Bauer, Iris Medits, et al.
Cancers|April 23, 2022
Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd VaccinationLorenz Schubert, Maximilian Koblischke, Lisa Schneider, et al.
Frontiers in Immunology|June 17, 2022
Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and VaccinationMarianne Graninger, Jeremy V Camp, Stephan W Aberle, et al.
NPJ Vaccines|July 31, 2020
Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipientsNicole Harrison, Katharina Grabmeier-Pfistershammer, Alexandra Graf, et al.
NPJ Vaccines|September 14, 2020
Erratum: Author Correction: Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipientsNicole Harrison, Katharina Grabmeier-Pfistershammer, Alexandra Graf, et al.
Pageof 8

Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Journal of Virology|May 3, 2014
Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope predictionJulia Schwaiger, Judith H Aberle, Karin Stiasny, et al.
Open Forum Infectious Diseases|July 25, 2022
The First Case of Usutu Virus Neuroinvasive Disease in Austria, 2021Marianne Graninger, Stefan Hubmer, Franz Riederer, et al.
The Journal of Infectious Diseases|November 12, 2010
Dynamic coinfection with multiple viral subtypes in acute hepatitis CJennifer A Smith, Judith H Aberle, Vicki M Fleming, et al.
The Journal of Infectious Diseases|April 3, 2007
CD4+ T cell responses in patients with chronic hepatitis C undergoing peginterferon/ribavirin therapy correlate with faster, but not sustained, viral clearanceJudith H Aberle, Gabriela Perstinger, Lukas Weseslindtner, et al.
European Journal of Preventive Cardiology|October 6, 2022
Immune response after mRNA COVID-19 vaccination in heart transplant recipients: long-term follow-up and evaluation of a third vaccinationSelma Tobudic, Keziban Uyanik-Ünal, Maximilian Koblischke, et al.
NPJ Vaccines|August 4, 2023
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variantsDavid N Springer, Michael Bauer, Iris Medits, et al.
Cancers|April 23, 2022
Immunogenicity of COVID-19 Vaccinations in Hematological Patients: 6-Month Follow-Up and Evaluation of a 3rd VaccinationLorenz Schubert, Maximilian Koblischke, Lisa Schneider, et al.
Frontiers in Immunology|June 17, 2022
Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and VaccinationMarianne Graninger, Jeremy V Camp, Stephan W Aberle, et al.
NPJ Vaccines|July 31, 2020
Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipientsNicole Harrison, Katharina Grabmeier-Pfistershammer, Alexandra Graf, et al.
NPJ Vaccines|September 14, 2020
Erratum: Author Correction: Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipientsNicole Harrison, Katharina Grabmeier-Pfistershammer, Alexandra Graf, et al.
Pageof 8